The new division will utilize Dip Pen Nanolithography nanofabrication techniques, in combination with proprietary detection systems, to produce uniquely sensitive assays for protein discovery and identification.
Femtofluidics handling of samples and reagents with these systems will help provide key benefits for users, including enhanced reaction kinetics and assay cost savings, the company said.
Bruce Dudzik, NanoInk’s senior director for business development, is leading the new unit. According to Mr Dudzik, the new division will be accessible to customers of all sizes.
James Hussey, CEO of NanoInk, said: “NanoInk is committed to developing applications for nanofabrication and partnering to find solutions for the challenges associated with life science research.”